Results 171 to 180 of about 48,282 (202)
Some of the next articles are maybe not open access.

[Resistance of enterobacteriaceae to carbapenems].

Klinicka mikrobiologie a infekcni lekarstvi, 2011
Carbapenems are the drugs of choice for the treatment of serious infections caused by ESBL- and AmpC-positive Enterobacteriaceae. An increasing trend of resistance to these antibiotics has been observed recently. The aim of the study was to determine resistance to carbapenems in clinical isolates of the Enterobacteriaceae family and its mechanism ...
M, Htoutou Sedláková   +5 more
openaire   +2 more sources

Options for treating carbapenem-resistant Enterobacteriaceae

Current Opinion in Infectious Diseases, 2014
To address the therapeutic management of carbapenem-resistant Enterobacteriaceae on the basis of literature of the last 12 months.Retrospective and prospective (nonrandomized noncontrolled) studies provide data regarding the management of infections due to carbapenem-resistant Enterobacteriaceae.
Petros I, Rafailidis, Matthew E, Falagas
openaire   +2 more sources

Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa

Journal of Medical Microbiology, 2013
Clonal dissemination of multidrug-resistant Pseudomonas aeruginosa (MDRPA) is a major concern worldwide. The aim of this study was to explore the mechanisms leading to the carbapenem resistance of an MDRPA clone. Isolates were obtained from a surgical wound, sputum, urine and a blood culture.
Ester, Fusté   +5 more
openaire   +2 more sources

[Carbapenem resistance in enterobacteria].

Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2009
Carbapenems are the drugs of choice in the treatment of serious infections caused by multiresistant Gram-negative bacteria. Clinically and epidemiologically, resistance to these beta-lactams poses the highest risk. In enterobacteria, two common mechanisms can cause the resistance to carbapenems: (1) hydrolysis of carbapenems by beta-lactamases and (2 ...
J, Hrabák, E, Chudácková
openaire   +1 more source

Role of glycosylation in bacterial resistance to carbapenems

World Journal of Microbiology and Biotechnology
Carbapenems are a class of β-lactam antibacterial drugs with a broad antibacterial spectrum and strong activity, commonly used to treat serious bacterial infections. However, improper or excessive use of carbapenems can lead to increased bacterial resistance, which is a significant concern as they are often used as last resort for treating multidrug ...
Jing, Dang   +5 more
openaire   +2 more sources

Carbapenem-resistant Enterobacterales in the USA

The Lancet Infectious Diseases, 2020
Sumanth, Gandra, Carey-Ann D, Burnham
openaire   +2 more sources

Screening for carbapenem-resistant bacteria

The Lancet Infectious Diseases, 2005
James S, Soothill, Paul E, Lock
openaire   +2 more sources

Carbapenem resistance

2020
Indranil Samanta, Samiran Bandyopadhyay
openaire   +1 more source

A Review of Carbapenem Resistance in Enterobacterales and Its Detection Techniques

Microorganisms, 2023
Evangelyn Alocilja   +1 more
exaly  

Home - About - Disclaimer - Privacy